The biophysical characteristics of vascular tissues are dependent largely on the properties of fibrillar collagens. Considering the predominant structural component, collagen type I, the present review describes the mechanisms of formation and maturation of lysyl oxidase-mediated cross-linking, leading to an understanding of how intracellular collagen-modifying enzymes affect the patterns of cross-links produced. An important distinction is made between the enzyme-mediated cross-linking, essential for optimum tissue function, and the non-enzymatic aging processes that generally lead to structural changes deleterious to function. Finally, the extracellular matrix of vascular tissue is a multicomponent system and the role of other major constituents, such as elastin and glycosaminoglycans, in modifying tissue properties should be considered. Some details of newer methods being developed to quantify these constituents will be presented.
Introduction
The biophysical characteristics of vascular tissues are dependent to a large extent on the properties of one of their main structural components, fibrillar collagens, comprising prominently collagen type I, but with significant amounts of collagen III. The presence of smaller amounts of other collagen phenotypes contributes to the control of fibril size and orientation, a process that is driven partly by the biomechanical demands of the tissue. The present review will, however, be restricted to considering collagen type I, describing the mechanisms of formation and maturation of lysine-derived cross-linking and understanding how intracellular changes in collagen-modifying enzymes affect the patterns of cross-links produced. An important distinction has to be made between the enzyme-mediated cross-linking, which is essential for optimum tissue function, and the nonenzymatic aging processes that generally lead to structural changes deleterious to function. Finally, the extracellular matrix of vascular tissue is a multicomponent system and the role of other major constituents, such as elastin and GAGs (glycosaminoglycans), in modifying tissue properties should be considered. Although this is beyond the scope of the present review, some details of newer methods that are being developed to quantify these constituents will be presented.
Lysyl oxidase-mediated collagen cross-linking
Stabilization of newly-formed, collagen fibrils occurs initially through the formation of difunctional, lysyl oxidase-mediated cross-links whereby lysine or hydroxylysine residues in the non-helical portions of the molecule (telopeptides) are converted into aldehydes, which then condense with hydroxylysine and other residues in neighbouring molecules to form intermolecular bonds. Although all crosslinking reactions subsequent to aldehyde formation occur spontaneously, these are facilitated by the highly ordered, three-dimensional array of collagen molecules within the assembling fibril, governed by hydrophobic and electrostatic interactions. According to the quarter-stagger model developed by Hodge and Petruska [1] , each molecule is staggered relative to the next by a distance of 67 nm, referred to as the D-period, with a gap of 0.6D between the C-terminal end of one molecule and the N-terminal end of the next. X-ray results [2] suggest that the most appropriate model is a compressed pentafilament. With these strict structural limitations, aldehydes within the N-and C-terminal telopeptides react with (hydroxy)lysine residues at position 930 and 87 respectively. Whether lysine or hydroxylysine residues are present in the telopeptides is crucial in directing the pathway of crosslink formation in a tissue-specific manner. In skin, where no telopeptide hydroxylation occurs, the intermolecular bonds formed are aldimines (Schiff bases), whereas in cartilage complete hydroxylation of telopeptide lysines leads initially to aldimines that are converted through Amadori rearrangements into keto-imines ( Figure 1 ): other tissues have varying relative amounts of these bonds depending on the degree of lysine hydroxylation [3] . Both aldimines and keto-imines can be stabilized by reduction with borohydride to facilitate their isolation and quantification.
In vivo, the reducible bonds are intermediates that are converted during maturation into non-reducible, more stable forms that are generally trifunctional. The aldimines react with a helical histidine residue to give HHL (histidinohydroxylysinonorleucine) [4] , whereas the keto-imines give rise to the pyridinium cross-links, PYD (pyridinoline) and DPD (deoxypyridinoline), and the corresponding pyrroles [5] . The hydroxylation of telopeptide lysine is accomplished intracellularly by a separate lysyl hydroxylase enzyme to that which hydroxylates lysine residues destined to be in the helix. This enzyme, the long form of lysyl hydroxylase-2 [6] , is, therefore, the primary control for the pattern of lysyl oxidase-mediated cross-linking in collagen. This enzyme may also influence fibrillogenesis as evidenced by overexpression in fibroblastic cells [7] . Increased expression of the long, spliced variant of lysyl hydroxylase-2, and the consequent increase in PYD cross-links in collagen has been linked to fibrosis [8, 9] , leading to attempts to inhibit the enzyme with the aim of preventing the irreversible accumulation of collagen [10] . Although it is clear that fibrosis is associated with increased PYD cross-links, the hypothesis that this results directly in a collagen matrix less susceptible to degradation [11] has yet to be verified.
Functionally, the importance of these lysine-derived crosslinks is well demonstrated by the effects of the lathyrogen, β-aminoproprionitrile, which, as an irreversible inhibitor of lysyl oxidase, results in the assembly of collagen fibrils lacking tensile strength because the pathways to cross-link formation are blocked. For example, the thoracic aorta of β-APN (β-aminoproprionitrile)-treated rats exhibited decreased mechanical stability with significant decreases in the mature collagen cross-link, PYD, without any change in the pyridinium cross-links of elastin [12] . The differential effects on function of the various types of lysine-derived cross-links are not well established, although it is clear that the transformation from intermediate to mature forms is accompanied by increased inter-microfibrillar bonding, a feature that results in transverse arrays of cross-links across the fibril, as shown by molecular modelling studies [13] , giving added resistance to shear stresses. One function of the intermediate, borohydride-reducible cross-links in collagen is possibly to allow rearrangements and remodelling of the fibrillar structure to occur before this additional transverse network of cross-links is put in place.
Age-related cross-linking
A second type of cross-linking mechanism that may also involve collagen lysine residues, but which is quite distinct from the lysyl oxidase-mediated processes, is that involving glycation or lipid oxidation products. Glycation has been the focus of much research [14] and the importance in vascular biology of AGEs (advanced glycation end-products) as well as their receptor, RAGE (receptor for advanced glycation end-products), is increasingly recognized [15, 16] . In contrast with the maturation of lysine-derived, intermediate crosslinks, formation of AGE-mediated cross-links in collagen is a true aging process that is generally deleterious to the function of the tissue. Thus AGE-related cross-linking was found to be associated with increased aortic wall stiffness in diabetic rats [17] , and increased concentrations of AGE products in serum was linked to arterial stiffness in hypertensive individuals, as measured by pulse wave velocity [18] .
An important difference between AGE-related crosslinking and the lysyl oxidase-mediated bonds is that the former are likely to occur between collagen helices and do not involve the telopeptides. This fact explains the major functional consequences in terms of tissue stiffness and increased resistance to enzymatic degradation. The major effect of interhelical cross-links on enzyme degradation of collagen is exemplified in skin collagen where increasing concentrations of an interhelical, histidine adduct cross-link, HHL, is matched by increased resistance to solubilization by pepsin [19] .
The structure and biochemistry of the many AGE compounds described to date will not be discussed in detail here, as this is the topic of another article in this issue [20] (pp. 853-856). In many cases, however, the amounts of specific forms of these compounds in collagen are too low to have any functional significance, and compounds such as pentosidine should be viewed as markers of an aging process rather than themselves being significant cross-links. Concentrations of the lysine-arginine cross-link, glucosepane, do, however, approach those of the lysyl oxidase-mediated crosslinks in skin collagen of the elderly [21] . Quantitative analysis of glucosepane and some other AGE compounds is, however, complicated by the fact that, unlike pentosidine, these components are unstable to acid and alkali hydrolysis procedures and require the use of complete enzymatic hydrolysis methods.
Other extracellular matrix constituents
The properties of cardiovascular tissue are dependent on many factors and, in addition to collagen cross-linking, it is important to be able to assess the contribution of different collagen types as well as measure the other principal constituents of the extracellular matrix, elastin and proteoglycans. This task is not straightforward, primarily because the intractability of cardiovascular tissue necessitates harsh methods to solubilize the tissue so that representative analyses can be obtained. Dye-precipitation methods have been used to quantify collagen and elastin in guanidinium chloride extracts of human carotid plaques [22] , but such methods appear to solubilize only a small proportion of the tissue and therefore give misleading results.
In addressing the problems of more accurately quantifying the major vascular constituents, collagens, elastin and GAGs, as well as measuring both the intermediate, reducible crosslinks and mature collagen cross-links, our approach has been to utilize digestion with CNBr, which solubilizes the collagen and other proteins but leaves the elastin component in the insoluble fraction because this protein lacks methionine residues. A newly developed scheme for the compositional analysis of cardiovascular tissue involves preliminary reduction with borohydride to facilitate analysis of the intermediate cross-links. Another important facet of the procedure is to powder the tissue under liquid nitrogen, incorporating a defatting step, to give homogeneous material suitable for representative subsampling. Portions are taken for GAG measurement in proteinase K digests using Dimethylmethylene Blue [23, 24] , with additional samples being digested with cyanogen bromide for collagen and elastin determinations. Under ideal conditions total collagen would therefore be determined by hydroxyproline assay in the solubilized fraction, whereas elastin would be quantified in the insoluble fraction by measurement of desmosines. In pilot experiments fractionating porcine coronary artery, almost complete fractionation of the structural protein fractions was achieved, with 98 % of the collagen being detected in the soluble fraction and a similarly high proportion of the elastin (desmosines) in the insoluble residue. For human carotid artery, however, not all of the collagen can be solubilized even with extended cyanogen bromide digestion, and the insoluble fraction, containing approx. 20 % of total collagen, also contains slightly higher relative proportions of the collagenous pyridinium cross-links. Nevertheless, this limited tissue digestion provides a more accurate reflection of tissue contents than methods involving only guanidinium chloride extraction, which probably solubilize less than 10 % of the collagen. Also, as the cyanogen bromidederived peptides of different collagen isotypes are well characterized, another potential advantage of the proposed methodology is that quantification of the different collagen types can be achieved by further analysis of the solubilized material. This can be done by quantitative analysis of marker peptides separated by SDS/gel electrophoresis [19] , although proteomic techniques are also being developed.
Measurement of cross-links
HPLC methods for determining the pyridinium cross-links of mature collagen using their natural fluorescence are well established [25] , and these have been combined with solidphase extraction to provide a robust method for analysis of tissue hydrolysates and physiological fluids [26] . For cardiovascular tissue analysis, it was important to measure the intermediate, reducible cross-links as the relationship between these and the mature bonds gives some indications of the level of collagen turnover. Assay of the reducible crosslinks was initially performed using radiolabelled borohydride [27] but modified amino acid analyser methods have been applied [28, 29] . We initially developed an ion-exchange chromatography method with post-column derivatization with orthophthalaldehyde but, when applied to borohydridereduced tissue hydrolysates, found serious interference from components that were later identified as reduced desmosines. These observations indicated that the elastin component of cardiovascular tissues presents specific problems in quantifying the reducible cross-links by conventional methods, and also prompted caution in using desmosines to quantify elastin under these conditions. Only the reduced forms of desmosines react with orthophthalaldehyde and, because only partial reduction of these compounds occurs under the normal conditions of borohydride treatment, both the reduced and non-reduced forms of desmosine need to be quantified in order to assess fully the elastin component.
The advent of newer technologies for cross-link measurement using LC/MS/MS (tandem MS combined with liquid chromatography) has circumvented many of the problems in the analysis of cardiovascular tissues. With this method, effluent from the chromatography is introduced into the first stage mass spectrometer, and specific cross-link components, characterized by their mass, are fragmented to ions with masses again characteristic of particular cross-links, which are detected in the second stage mass spectrometer. Thus, in a process referred to as multiple reaction monitoring, a series of transitions from parent ion mass to that of the fragment is followed for each of the cross-links being measured. The method allows measurements of multiple cross-links in a single chromatographic run and these do not necessarily have to be separated completely by chromatography as each measured mass transition relates to a specific cross-link. Internal standards used for these types of assays should be similar in character to the compounds being analysed. In our case, the di-and tri-functional aliphatic cross-links were quantified with respect to 2 H-labelled DHLNL (dihydroxylysinonorleucine), whereas the pyridinium cross-links were measured in relation to a 2 H-labelled desmosine derivative. Addition of these internal standards after tissue hydrolysis also allowed corrections to be made for losses during the sample prefractionation procedures. Using these methods, we have now developed assays to measure the aliphatic reducible cross-links [in reduced form as DHLNL and HLNL (hydroxylysinonorleucine)], as well as PYD, DPD and both reduced and non-reduced forms of the desmosines.
Concluding comments
The overall aim of these studies is to provide information on how changes in the extracellular matrix affect the properties of both normal and diseased cardiovascular tissues. To date, there is relatively little information on the types of cross-links present in atherosclerotic plaque and the surrounding tissue, and such studies may be crucial in understanding both the aetiology of plaque formation as well as how it becomes vulnerable to rupture.
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